THYMOSIN ALPHA 1

---

 Thymosin Alpha-1 (Tα1) is a naturally occurring thymic peptide consisting of 28 amino acids, originally isolated from the thymus gland.

It plays a fundamental role in immune system regulation, inflammation control, and cellular defense, making it one of the most studied immunomodulatory peptides in medical and research settings.

Thymosin Alpha-1 acts as an immune system modulator, enhancing both innate and adaptive immunity.

It influences T-cell differentiation, cytokine production, and antiviral responses through the following mechanisms:

1. Upregulation of T-cell activity – supports immune surveillance and response
    
2. Activation of dendritic cells & NK cells – strengthens innate defense mechanisms
    
3. Modulation of cytokines – balances pro- and anti-inflammatory signals
    
4. Enhanced vaccine response – shown to improve immune readiness in studies
    
5. Cellular protection – promotes resilience against oxidative and infectious stress
    

Immune modulation

Improved T-cell and NK-cell function

Antiviral research

Enhanced resistance against viral replication

Inflammation control

Balanced cytokine and immune signaling

Oncology research

Synergistic effects with immunotherapies

Systemic wellness

Improved stress and immune response profiles

Injectable (subcutaneous)

0.5 – 1.5 mg

2–3 times per week

Extended studies

1.6 mg – 3.2 mg per week total

Cyclic or ongoing

• Cycle duration (research): 4–12 weeks
   
• Half-life: ~2 hours (short-acting immune peptide)
   
• Combination studies: Frequently researched with Thymosin Beta-4 (TB-500) and Interferon-α for synergistic effects